07:00 , Jul 17, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Lipodystrophy Phosphate cytidylyltransferase 1 choline-a (PCYT1A) Biochemical and cell-based studies identified PCYT1A mutants that could be targeted to treat congenital lipodystrophies. Genetic sequencing and...